The Limits of Aging & Implications

Originally broadcast November 6, 2024

The current life expectancy at birth is 74.8 years for males and for females it’s 80.2 years in the U.S. Does it catch your eye when you hear about predictions we’ll be able to live to 100 and beyond? Some researchers are throwing cold water on those notions. “We’ll be lucky if 5% of the age cohort makes it to 100,” says S. Jay Olshansky, Ph.D., Professor, University of Illinois at Chicago.

He and his colleagues made headlines when they presented data that humans are approaching a biologically-based limit to life. Hosts Mark Masselli and Margaret Flinter ask Olshansky about the implications of this research — for each of us personally and for policymakers — after decades of hearing predictions that life expectancy would continue to go up. Olshanky explains why we should celebrate longer life that has resulted from healthier diets and medical advances but now focus on improving quality of life in later years.

This transcript was exported on Dec 05, 2024 - view latest version here .

Mark Masselli ( 00:04 ):
We are literally in the final days of the 2024 presidential race, what will the voters decide? How will
healthcare matter in the race and what will the outcome mean to each of us?

Shannon Firth ( 00:15 ):
I've spoken with or at least seen that there are other physicians who are Republicans who are kind of
hedging or at least shifting their views a little bit in terms of how they speak about abortion, and I think
that may not be just physicians. I think that's probably across the board that people who are running in
maybe more purple states especially may be more careful.

Margaret Flinter ( 00:41 ):
We are convening our Reporters Roundtable to talk with the journalists who are covering the health
policy and politics of this nail-biting race. They are Shannon Firth, MedPage today's correspondent in
Washington and Sarah Owermohle, who reports on federal issues for Stat News

Sarah Owermohle ( 00:57 ):
That people generally do when they're asked the question of limiting abortion access, they will side with
access with of course, some restrictions or conditions on that.

Margaret Flinter ( 01:08 ):
This is Conversations on Healthcare.

Mark Masselli ( 01:19 ):
Welcome to both of you and to Conversations on Healthcare. Let's start off by discussing a Newsweek
poll that showed abortion has overtaken immigration as the second most important issue for voters
heading into November. And I'm wondering, Shannon, you interviewed an OBGYN who's running for the
U.S. House in Minnesota as a Democrat. What did you learn from that story and the political
consequences for other races?

Shannon Firth ( 01:46 ):
Yes. Thank you so much again for having me here on Conversations on Healthcare, I interviewed Dr.
Kelly Morrison, who is running in Minnesota. She's been in the state legislature for a few years now.
She's running for the open seat in Minnesota. She is very pro-abortion rights. She is very concerned
about her colleagues around the country who have been impacted by abortion bans. She says it's absurd
that physicians have to contact legal counsel in emergency situations to try to make decisions about the
best care for patients while trying to keep themselves and their hospital out of trouble.
( 02:32 ):
She's also done a lot of work to try to, I guess one of the things that I asked her was, if you cannot
reinstate Roe vs. Wade, if there aren't the votes in Congress, if say you are elected. I asked her, what are
other measures? And she pointed to the military and just said, it's really important to make sure that we
follow their lead in terms of trying to help people access care wherever they can get it. So again, she's
been passing forward. She's helped Minnesota pass protections in her state. Of course, Tim Walz is
governor of Minnesota, is the VP candidate right now. So I think she would be a very strong voice for
abortion rights if she were elected.

Transcript by Rev.com

This transcript was exported on Dec 05, 2024 - view latest version here .

Mark Masselli ( 03:19 ):
Shannon, I heard the other day that Liz Cheney was talking, a pro-life person, who was talking about this
issue of the confusion that it's caused in terms of the healthcare delivery for both pro-life, pro-choice
women across the country. Maybe talk a little bit about that view that's rising up in the campaign and
probably one of the reasons that's moved this issue up past immigration.

Shannon Firth ( 03:47 ):
Yeah, I think it's really interesting to hear people like Liz Cheney who is a anti-abortion policy person and
has been a really strong voice in the conservative movement talk about we need to make sure that
miscarriage management is available and that we're not restricting all kinds of care here. And of course,
as we know, Liz Cheney supports Kamala Harris, and I think also I've spoken with or at least seen that
there are other physicians who are Republicans who are kind of hedging or at least shifting their views a
little bit in terms of how they speak about abortion. And I think that may not be just physicians. I think
that's probably across the board that people who are running in maybe more purple states especially,
may be more careful about how they speak about abortion, recognizing how public consensus, public
opinion feels about this issue.

Margaret Flinter ( 04:56 ):
Well, Sarah, you recently traveled to Montana, which is one of 10 states with an abortion rights
referendum on the ballot. What did voters that you talked to on the ground tell you, and how do you
think this sentiment could affect the Senate race there?

Sarah Owermohle ( 05:13 ):
Yeah, so as you said, there's 10 states voting on it this year, and overwhelmingly those states are voting
on ensuring access to abortion, with the exception that Nebraska has two opposing ballot measures in
front of them, one that would ensure access, one that would limit. And what I found in Montana is what
we're hearing in general in different states in this election and in the prior ballot measures that have
been passed in other states that people generally do when they're asked the question of limiting
abortion access, they will side with access with of course some restrictions or conditions on that.
( 05:49 ):
And so that's the confidence that a good amount of people have in Montana that that's the way that it's
going to go. But not the same confidence in the Democratic Senate candidate. He's lagging the polls,
John Tester, and look at this and look at other states that have kind of the same narrative going on.
Arizona and Florida also have abortion ballots in front of them, and also will probably elect Republicans
if we're looking at the polls, but could still side with abortion rights.
( 06:18 ):
And so it's this sort of dichotomy where people know that this is what they feel they don't want those
restrictions as Shannon was talking about with Liz Cheney for instance. There's different nuances here
that people don't want to see put into their healthcare, but their political identities are still their political
identities. So I think that we can safely assume at this point that Republicans will have control of the
Senate, just that these states might be also ensuring abortion access in their states.
( 06:48 ):
And I would say just one more thing there, 10 states are voting on this this year. It's the most since Roe
fell, but there are not very many states left that have this mechanism in front of them to have a ballot

Transcript by Rev.com

This transcript was exported on Dec 05, 2024 - view latest version here .

initiative before their voters. So this is the last time really that we are going to see this amount of states
voting on that.

Mark Masselli ( 07:06 ):
And really the two swing states are Nevada and Arizona where it's on of the 10. But any impact, we see
that the Texas race is close. They passed a very restrictive policy there. I'm not sure what's driving those
numbers, but Cruz is ahead, I think by just a few points, I haven't followed it as of today, but it seems to
be a close race. Any thought that this issue's resonating there?

Sarah Owermohle ( 07:40 ):
I think that's Democrats hope for sure. And as you said, this has moved up in polls as a primary issue for
people. That's very important to Democrats to raise the stakes and to remind people that women's
healthcare is on the ballot essentially. And that's I think why Vice President Harris was in Texas last
week. I think her campaign circuits are pretty clear that they don't think she might win Texas, but that
she in this backdrop of a state with a ban and she can really draw attention to that there. And she did.
And I think that's going to be something that we're going to just see so much of in this next week and a
half or how much that we have in front of us just raising the stakes, sharpening what the arguments are
here.

Margaret Flinter ( 08:21 ):
There's diametrically opposite views in many areas of this election, and certainly that's true of issues
surrounding the Affordable Care Act, which right now includes enhanced subsidies for low and middle
income people on the health insurance exchanges, which I think has been very popular. These subsidies
are set to expire next year if former President Trump and the Republicans take control. What do you
foresee this really meaning for the Affordable Care Act?

Sarah Owermohle ( 08:47 ):
Well, it's a big part of what the enrollment numbers have been in the Affordable Care Act lately. So the
Biden administration has touted record numbers of enrollment, record numbers of coverage over these
last few years, and a very big part of that is those subsidies that they keep costs low for many people.
With them set to expire in 2025, there's sort of this dilemma in front of everyone, especially Republicans
where a lot of the people who benefit from those subsidies are in conservative states and in states that
have not expanded Medicaid.
( 09:18 ):
And so if those subsidies end, a lot of people who are going to feel that are conservative state voters.
And so there's discussion of how we make those subsidies different. Essentially, we've heard from a lot
of people who were former Trump administration officials or who are associated with the campaign
these days about how those subsidies look different, how we apply them differently, how we separate
risk pools in insurance and let healthier people have lower costs. There's a lot there that Trump himself
has not gotten into. He has not talked specifically about this, so we can only rely on what people around
him have said, but he has assured us that he's not going to repeal ACA. He's just looking at basically
every option that's in front of him.

Mark Masselli ( 10:07 ):

Transcript by Rev.com

This transcript was exported on Dec 05, 2024 - view latest version here .

Interesting. Sarah, you reported on the slogan used by some Republicans. It says Make America Healthy
Again, but it has a anti-science and anti-vaccine bent to it. I'm wondering if you could take our listeners
through the Republicans' approach and maybe shine a light on who's behind it.

Sarah Owermohle ( 10:29 ):
Yeah, so Make America Healthy Again, obvious parallels to Make America Great Again, intentional.
Robert F. Kennedy is one of the main people behind this, and he has been closely associated with
Trump, especially since he dropped out of the race himself. He's on Trump's transition team even this
weekend. Trump was saying that he is committed to putting Kennedy in his administration somehow.
There's many arms to the Make America Healthy Again, movement. A lot of it has to do with food policy,
chronic illnesses, how to better manage chronic illnesses.
( 11:02 ):
But also a lot of it has to do with this idea that public health agencies are not always incentivized to
make the right decisions for people because of pharmaceutical industry influence. And that's the part
that has a lot of people nervous because there's Robert F. Kennedy himself has had anti-vaccine
commentary in the past, and he said in more recent months that that's not how he feels, but the record
is there, and the way that he's discussing the pharmaceutical industry and the review that agencies like
the Food and Drug Administration have of these drugs, we already have a confidence issue in the United
States towards vaccines, towards treatments.
( 11:44 ):
And so it has a lot of people nervous about what he would do and who he would pick to be the people
who oversee these very agencies. So I think it's a discussion that we're still going to see happen over the
next few weeks. Trump has absolutely doubled down on Kennedy having some sort of role, but I'll note
that he said that his first time that he got elected and Kennedy was not there. So we can have a little bit
of a reality check here. And certainly of course Kennedy, if he was to be put up for any position like HHS
secretary, that's a Senate confirmed position, so we don't think that's what's going to happen. But could
he be in the White House? Could he have a lot of influence? Absolutely.

Mark Masselli ( 12:27 ):
And if you looked at the many of the authors while they have put some distance behind the 2025 Project
and the campaign, would we be surprised not to see some of the folks who helped author some of the
health sections perhaps somewhere in the administration?

Sarah Owermohle ( 12:50 ):
I think that's a safe assumption. I mean, a lot of the authors of Project 2025 were former Trump officials,
and I know that he has distanced himself from a lot of that, especially the health section, but he's not
distanced himself entirely from that. I think that the main thing that he has said that he would not do is
what was discussed in terms of abortion policy. There's other parts of that, especially the notions of
reforming and restructuring public health agencies that I think that he has signaled he would be on
board with some of that. And we can see that even with him associating with Kennedy and the Make
America Healthy Again alliance. And so I think that we can look at some of those authors and a lot of
other former Trump officials and say those people might be back.

Mark Masselli ( 13:34 ):

Transcript by Rev.com

This transcript was exported on Dec 05, 2024 - view latest version here .

Remind me, are the positions like the FDA and CDC coterminous with the presidents or do they have an
overlapping, like the Federal Reserve Board is not tied to the term of the president. What do we know
about those other positions?

Sarah Owermohle ( 13:53 ):
They are not necessarily tied to the term of the president, but the president does have to say that they
would want that person to continue in that role. And a good point there as well, CDC was not a Senate-
confirmed position. This next year will be the first time.

Margaret Flinter ( 14:11 ):
Shannon, you wrote an in-depth story about Donald Trump's health. We sort of hear about the health
generally, but we don't hear a lot about specifics. What do we know and don't know about his physical
and mental condition right now and how does that compare to what Kamala Harris has shared about her
health?

Shannon Firth ( 14:29 ):
Yes. Well, we know about Donald Trump's health. We've kind of learned over the years, probably the
first public report that I remember was Dr. Harold Bornstein talking in his letter about Trump's excellent
health. And as we know, that letter was dictated by Donald Trump himself as Dr. Bornstein later
revealed.
( 14:51 ):
But more recently, what we know about his health from White House reports while he was in office
include that he's on certain medications. He takes a statin, Rosuvastatin, or also known as Crestor for it's
cholesterol lowering drug. He takes Propecia for hair loss and he takes another drug, sorry, an
ivermectin cream for his rosacea. I mean, those are all pretty, I would say normal things. He did get
COVID, and we know from reports in the New York Times that he really downplayed how much he'd
been impacted by COVID. There were reports from some officials close to him, familiar with his medical
case at the time that they thought he might need to be put on a ventilator. Meanwhile, early on, he kind
of was very much saying that he was doing fine and that wasn't really the case.
( 15:54 ):
We also have a sense that maybe in 2019 when he took the sort of mystery trip to Walter Reed, we
heard from a White House press secretary later on that that was most likely for, she said that it was for a
routine colonoscopy, which I guess Trump didn't really want people to know at the time. That's never
been confirmed. And then of course, most recently of all, we have the attempts on his life. Looking at
those, we know that very little actually. We know that Ronnie Jackson released the only real report on
his health after that, basically saying the bullets or pieces of bullet grazed his ear and that he had
bleeding and swelling on his upper right ear. He did get a CT scan. It was reported that he got a CT scan.
We never saw full results from that, which are important to know because anything coming that close to
your head at that with that amount of power could cause other issues.
( 17:05 ):
And in terms of his mental health, Stat actually did a really great piece that looked at analyzing his
cognition, basically his verbal abilities. I think this was the second time they got experts to analyze his
speech and notice that he was using shorter phrases, was more repetitive, had a lot more digressions. As
far as his mental health, that was looked at pretty closely by Mepisha Day back during his first

Transcript by Rev.com

This transcript was exported on Dec 05, 2024 - view latest version here .

administration when he first elected. There were calls by mental health professionals to say that he
basically has a serious mental illness and should not be in office. And there were petitions. There was a
lot of discussion around that.
( 17:59 ):
Or one disorder in particular, we interviewed Dr. Francis Allen, who is the person who defined the
criteria, the DSM Diagnostic Statistics Manual criteria for narcissistic personality disorder, which is
something that people thought that he might have. And he said, "No, he's a world-class narcissist, but
he does not have the actual disorder." And in terms of, I guess other mental health and cognitive issues,
I think everyone would like to know more about the possibility that he has PTSD after two attempts now
in his life in just a short period. I don't know if we are going to hear any more or get any more
information from him about a medical report from him. He promised one back in August. We haven't
seen anything substantive since the Ronnie Jackson memo, Ronnie Jackson being his former White
House physician who's now in the U.S. Congress.

Mark Masselli ( 19:07 ):
Any abnormal findings in Vice President Harris's medical record?

Shannon Firth ( 19:16 ):
Kamala Harris and her physician a put out a report very recently said that there's basically no findings of
significance. She takes medication for hives, she takes medication for allergies, very normal things. She
wears contact lenses. She's very active and healthy and eats nutritious meals. There wasn't anything
that stood out in her vitals. Her mother died of colon cancer. So that was one of the things that
MedPage had actually asked the campaign like we'd love to know more about what's her health histor?
Has she had a colonoscopy? They have set at all routine screenings for all of her mammograms. So there
isn't anything of note that came out of that or that would be worrisome in terms of serving a term as a
president that came out of her medical report.

Mark Masselli ( 20:17 ):
You mentioned the word COVID, which we've not heard a lot about in the campaign, and yet maybe to
both of you, long COVID's had an enormous impact on so many people across the country. Many
Americans want to have it in their rearview mirror at this point, but where do we stand in any
conversation about COVID, the potential for another pandemic to come, our readiness for the continued
mutations that are happening with the virus? What are you hearing or has it kind of all gone silent?

Shannon Firth ( 20:52 ):
I think a lot will depend on this election in terms of pandemic preparedness. If Republicans or a
Republican administration wants to deplete or reform the FDA, the CDC, I think it will be a lot more
challenging to keep an eye on COVID and on any other future pandemics. I also know that there was
talk, I'm not sure if this is still the case, but there was talk from Trump about getting rid of the White
House office of Pandemic Preparedness, which I think a lot of physicians or a lot of infectious disease
physicians in particular would be concerned about. Given that the only reason we had some preparation
to begin with is because of people like Anthony Fauci and others thinking through years back, the need
to sort of get ready for this and sounding the alarm years and decades earlier.

Margaret Flinter ( 22:02 ):

Transcript by Rev.com

This transcript was exported on Dec 05, 2024 - view latest version here .

Well, President Obama certainly made a point about that on a recent newscast about having spent so
much energy in the White House developing the preparedness plan and didn't think it was particularly
picked up subsequently, but I'm sure it's still rests there in the archives at least. A question for either of
you really, when it comes down to it, so much of governing relates to the people who are in charge
under the President. We're curious, who are the candidates that you've identified to lead the U.S.
Department of Health and Human Services on both sides? You talked about Kennedy, probably not, but
who are the leading candidates and how public are they about expressing interest in the job right now?
Is there any kind of lead candidates emerging?

Sarah Owermohle ( 22:52 ):
I can jump in first. In terms of the last question, how public are they generally, that's not seen as a good
thing. It certainly isn't seen as a good thing with the Harris and Biden folks that someone would be
publicly campaigning, so they're being very careful about their interest. On the Trump side, I'd say it's
more of the same too. People's names are in the ring, but to be seen as going out and saying that you
want this, it's not seen well. But we can with both of them, think of some of the people that have
already been prominent, whether it's in the first Trump administration or in the Biden administration
currently.
( 23:32 ):
So if we go Harris first, we can think of some of the people like the CDC director right now Mandy
Cohen, or people who have been vetted for a position and then didn't have it, like the New Mexico
governor, Michelle Lujan Grisham. And in the Trump administration, I would say it's a little bit also
similar to that, that there will be people coming back who were there the first time around. We could
even see someone like Scott Gottlieb, who was FDA director. Left on good terms with him, coming back
around in some sort of position.
( 24:08 ):
And then we are seeing some people that I would say are openly campaigning for a job. So the former
CDC director, Robert Redfield, has fully thrown his support behind the Make America Healthy Alliance.
He's been talking on news networks about it. He penned an op-ed in Newsweek about this. I could see
that that is clearly vying for a position. And so yeah, some familiar faces, I think in both administrations
would be background.

Shannon Firth ( 24:33 ):
I think Sarah covered a lot of people, but in terms of the Harris administration, I also have heard
Governor Michelle Lujan Grisham CDC Director, Mandy Cohen. Lujan Grisham has been really outspoken
in terms of trying to speak out about abortion bans. CDC director, she had a lot of bipartisan support
when she came in. I think she's been really focused on building up public trust in public health again,
Vivek Murthy is a name that's been floated. I'm not sure that that would happen, but his name has been
mentioned. Chiquita Brooks-LaSure, CMS director, and Andrea Palm, who's the Deputy Secretary of HHS
all have been mentioned. But again, I think maybe Mandy Cohen and Lujan Grisham, who officiated
Kamala Harris wedding, or no, sorry, other way around. Harris officiated her wedding.
( 25:36 ):
And on the Republican side we hear names like Paul Mango, Bobby Jindal, Joe Grogan, Brian Blaze of the
Paragon Health Institute, and then also Eric Hargan. Those have all been touted as possibilities. Again,
RFK could be in the mix again. I again with Sarah feel like that confirmation hearing would be really
interesting. But I do think that Trump once has said to I guess whether, I can't remember if it was the

Transcript by Rev.com

This transcript was exported on Dec 05, 2024 - view latest version here .

Wall Street Journal of the New York Times that has said that he wants him somewhere in his cabinet,
and whether that's FDA, CDC, HHS, USDA, I'm not really sure at this point, but I think he's gunning for
something

Mark Masselli ( 26:23 ):
To both of you. Let's just go one level below and look at the important committees that deal with
healthcare in the House and Senate. I'm wondering what changes could occur in the new session, and
maybe to the extent that you have an insight, who's jockeying for the role of committee chairs in their
respective bodies?

Shannon Firth ( 26:43 ):
I'll speak to the Senate. I think that in terms of the Senate health committee, if Republicans take the
Senate, I think the next in line might be Rand Paul, but he seems to be looking outside of health. He may
want to be on other committees. So that would put Senator Cassidy, who's a gastroenterologist from
Louisiana that would put him as in charge of the health committee as chair there.
( 27:14 ):
And I think his priorities are a little different than Sanders, but I think we could see some more of the
same discussions. I don't think anyone would be as strong as Sanders in terms of trying to bring down
drug prices and is focused on that and on things like private equity and healthcare. I don't think those
are as strong priorities for someone like Senator Cassidy. In terms of finance, the finance committee, we
could see potentially Mike Crapo move up in that position. I don't know as much about the House where
things would stand there, but maybe Sarah can speak to other things.

Sarah Owermohle ( 28:01 ):
I can jump in on the House and just voice what you said about the Senate. I think that we could probably
see Cassidy being the head of the health committee because as you said, Rand Paul seems to have some
other objectives, and Cassidy is pretty invested on some of these issues. On the house side, it's already
under Republican control, so we can imagine that some of those chairmanships are going to stay the
same. But one notable one is that Energy and Commerce Committee, which does oversee a lot of the
healthcare industry, a lot of the agencies, Kathy McMorris Rodgers is retiring, and so we could probably
expect that some of her deputies, someone like Morgan Griffith or Brett Guthrie could be the head of
that committee.
( 28:42 ):
I think that's probably going to be one of the most important committees to watch because that has
been the vehicle for a lot of the discussion of public health reform. It's also been the vehicle for a lot of
things that have just been shelved sometimes, but still seem to be priorities like regulating pharmacy
benefit managers, drug costs, what happens in that realm. And so I think that we can expect in the other
House committees that the leadership will generally stay the same. Energy and Commerce a little bit of
shuffling up, but they're going to have those priorities in front of them still.

Margaret Flinter ( 29:12 ):
Well, maybe a question for either of you, maybe we can forget that Congress will actually be back this
year for the lame duck session, but there are a lot of issues before it. Certainly includes an issue, very
important to our audience, the reauthorization and funding of community health centers, but other

Transcript by Rev.com

This transcript was exported on Dec 05, 2024 - view latest version here .

issues such as telehealth, pharmacy benefit managers, other bills. Would you like to do a crystal ball on
what will happen after November 5th with these issues?

Shannon Firth ( 29:42 ):
I'll just say I think that Telehealth, they need to act on that issue quickly as far as changes in terms of
PBMs and community health centers, I do think that there's appetite for addressing the PBM issue. I just
don't know how... They've been talking about it. I don't know how many hearings Sarah and I have both
listened to about PBM reform explaining over and over all the different players and what the problems
are, and I don't know if there's going to be movement, but there could be. So those are my thoughts.

Mark Masselli ( 30:23 ):
Well, Shannon and Sarah, thank you so much for joining us today on Conversations on Healthcare. We
remind everyone to vote so your voice is heard, and don't forget to subscribe to our videos on YouTube
and find us on Facebook and X with our account name CHC Radio. As always, you can go online to
CHCradio.com to sign up for emails, updates. You can also share your thoughts and comments about
this program. Again, thank you both for joining us and for your insight into what is about to be settled
sometime in November, hopefully before January. Take care now.

Margaret Flinter ( 31:01 ):
This copyrighted program is produced by Conversations on Healthcare and cannot be reproduced or
retransmitted in whole or in part without the express written consent from Community Health Center
Inc. The views expressed by guests are their own, and they do not necessarily reflect the opinion of
Conversations on Healthcare or its affiliated entities.

Transcript by Rev.com